Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018)
Sutro Biopharma (STRO) reported Other Non Operating Income of $1.1 million for Q4 2018, up 794.17% on a YoY basis from $120000.0 in Q4 2017, and up 1677.94% sequentially from -$68000.0 in Q3 2018.
Sutro Biopharma (STRO) Other Non Operating Income (2017 - 2018) Analysis & Trends
Sutro Biopharma (STRO) has 2 years of Other Non Operating Income data on file, last reported at $1.1 million in Q4 2018.
- For the quarter ending Q4 2018, Other Non Operating Income rose 794.17% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2018 stood at $945000.0 (changed N/A YoY), and the FY2025 full-year result was $148000.0, changed N/A from the prior year.
- Other Non Operating Income rose to $1.1 million in Q4 2018, from -$68000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q4 2018 to a low of -$180000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | -68,000.00 |
| Dec 31, 2017 | 120,000.00 |
| Sep 30, 2017 | -180,000.00 |